Dennis Docker
Overview
Explore the profile of Dennis Docker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zelba H, Kyzirakos C, Kayser S, Shao B, Reinhardt A, Pieper N, et al.
Vaccines (Basel)
. 2024 Apr;
12(4).
PMID: 38675779
Ovarian cancer is one of the most common cancers among women and the most lethal malignancy of all gynecological cancers. Surgery is promising in the early stages; however, most patients...
2.
Brenner D, Baumgartner T, von Spiczak S, Lewerenz J, Weis R, Grimmer A, et al.
Neurol Res Pract
. 2020 Jun;
1.
PMID: 32587944
Background: Lafora progressive myoclonus epilepsy (Lafora disease) is a rare, usually childhood-onset, fatal neurodegenerative disease caused by biallelic mutations in (Laforin) or (, Malin). The epidemiology of Lafora disease in...
3.
Brenner E, Schorg B, Ahmetlic F, Wieder T, Hilke F, Simon N, et al.
Nat Commun
. 2020 Mar;
11(1):1335.
PMID: 32165639
Immune checkpoint blockade (ICB)-based or natural cancer immune responses largely eliminate tumours. Yet, they require additional mechanisms to arrest those cancer cells that are not rejected. Cytokine-induced senescence (CIS) can...
4.
Forschner A, Battke F, Hadaschik D, Schulze M, Weissgraeber S, Han C, et al.
J Immunother Cancer
. 2019 Jul;
7(1):180.
PMID: 31300034
Background: Metastasized or unresectable melanoma has been the first malignant tumor to be successfully treated with checkpoint inhibitors. Nevertheless, about 40-50% of the patients do not respond to these treatments...
5.
Hickmann A, Frick M, Hadaschik D, Battke F, Bittl M, Ganslandt O, et al.
BMC Cancer
. 2019 Mar;
19(1):192.
PMID: 30823914
Background: Central nervous system lymphomas (CNSL) is a devastating disease. Currently, a confirmatory biopsy is required prior to treatment. Objective: Our investigation aims to prove the feasibility of a minimally-invasive...
6.
Sonntag K, Hashimoto H, Eyrich M, Menzel M, Schubach M, Docker D, et al.
J Transl Med
. 2018 Feb;
16(1):23.
PMID: 29409514
Background: Cancer vaccines can effectively establish clinically relevant tumor immunity. Novel sequencing approaches rapidly identify the mutational fingerprint of tumors, thus allowing to generate personalized tumor vaccines within a few...
7.
Platzer K, Yuan H, Schutz H, Winschel A, Chen W, Hu C, et al.
J Med Genet
. 2017 Apr;
54(7):460-470.
PMID: 28377535
Background: We aimed for a comprehensive delineation of genetic, functional and phenotypic aspects of encephalopathy and explored potential prospects of personalised medicine. Methods: Data of 48 individuals with de novo...
8.
Docker D, Schubach M, Menzel M, Spaich C, Gabriel H, Zenker M, et al.
Eur J Hum Genet
. 2014 Jun;
23(3):409-12.
PMID: 24939587
Megalencephaly-capillary malformation (MCAP) syndrome is an overgrowth syndrome that is diagnosed by clinical criteria. Recently, somatic and germline variants in genes that are involved in the PI3K-AKT pathway (AKT3, PIK3R2...
9.
Docker D, Schubach M, Menzel M, Munz M, Spaich C, Biskup S, et al.
Eur J Hum Genet
. 2013 Dec;
22(8):1034-9.
PMID: 24301056
SATB2 is an evolutionarily highly conserved chromatin remodeling gene located on chromosome 2q33.1. Vertebrate animal models have shown that Satb2 has a crucial role in craniofacial patterning and osteoblast differentiation,...
10.
Docker D, Walther A
Anasthesiol Intensivmed Notfallmed Schmerzther
. 2012 May;
47(5):296-305.
PMID: 22628025
The use of muscle relaxants facilitates endotracheal intubation and ameliorates the conditions of surgery. But, their use should be controlled - otherwise there will be postoperative residual curarisation which can...